TSLA
Tesla
-- 222.150 NVDA
NVIDIA
-- 106.980 PLTR
Palantir
-- 76.380 AAPL
Apple
-- 227.480 MSTR
Strategy
-- 239.270 
NEWS
Petros Pharmaceuticals Featured in "New Era of Healthcare, AI, Data and Consumer Empowerment"
Thursday, 19th December at 9:15 am
Company positions itself for new innovation utilizing AI and quantum computing to help expand patient access to drugs via OTC access
NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announced that in a recent podcast, The Intelligent Leadership Podcast, titled, "The New Era of Healthcare, AI, Data and Consumer Empowerment," Petros President Fady Boctor discussed the Company's concerted efforts to develop its proprietary platform as a prospective technology driven Rx-to-OTC switch solution across a multitude of conditions and existing Rx only therapies.
During the podcast, Boctor discussed Petros' technology tool development around a Drug Facts Label to self-select, as well as the utilization of AI to ensure safe engagement and access to a drug that has made the Rx-to-OTC switch. This previewed the Company's future strategic direction, demonstrating a thought-out approach that included the role of technology and AI in pharma [00:44], building a self-service platform [06:42], challenges and oversight in AI implementation [17:21], and future trends in healthcare and technology [25:22].
Boctor, in underscoring the opportunity to utilize technology to expand access, said during the podcast, "We're starting to empower consumers to make decisions and seek those treatments for themselves, leveraging their own custom healthcare data." He later emphasized the Company's belief that technology would be the way this might be executed, adding, "In many respects, we have high bets on technology led by way of artificial intelligence, but so much more."
Petros has developed a proprietary technology-assisted platform that,
Thursday, 19th December at 9:15 am
Company positions itself for new innovation utilizing AI and quantum computing to help expand patient access to drugs via OTC access
NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announced that in a recent podcast, The Intelligent Leadership Podcast, titled, "The New Era of Healthcare, AI, Data and Consumer Empowerment," Petros President Fady Boctor discussed the Company's concerted efforts to develop its proprietary platform as a prospective technology driven Rx-to-OTC switch solution across a multitude of conditions and existing Rx only therapies.
During the podcast, Boctor discussed Petros' technology tool development around a Drug Facts Label to self-select, as well as the utilization of AI to ensure safe engagement and access to a drug that has made the Rx-to-OTC switch. This previewed the Company's future strategic direction, demonstrating a thought-out approach that included the role of technology and AI in pharma [00:44], building a self-service platform [06:42], challenges and oversight in AI implementation [17:21], and future trends in healthcare and technology [25:22].
Boctor, in underscoring the opportunity to utilize technology to expand access, said during the podcast, "We're starting to empower consumers to make decisions and seek those treatments for themselves, leveraging their own custom healthcare data." He later emphasized the Company's belief that technology would be the way this might be executed, adding, "In many respects, we have high bets on technology led by way of artificial intelligence, but so much more."
Petros has developed a proprietary technology-assisted platform that,
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment